Trump slams Pfiz­er’s drug price hikes, promis­es to re­tal­i­ate — but how?

Pfiz­er’s re­cent round of drug price hikes in the wake of Pres­i­dent Don­ald Trump’s promise of cas­cad­ing costs has drawn the at­ten­tion of the com­man­der-in-chief.

The Fi­nan­cial Times first re­port­ed that Pfiz­er had hiked prices on 100 prod­ucts at right around 9% for most, fit­ting un­der a 10% cap that most man­u­fac­tur­ers are hap­py to com­ply with. Just a few weeks ago, though, Trump caught the at­ten­tion of the in­dus­try when he promised that phar­ma com­pa­nies were about to de­liv­er “vol­un­tary mas­sive drops in prices.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.